High Cost of Weight-Loss and Diabetes Drugs in the US Compared to Other Countries, Analysis Reveals

Weight-loss drugs, such as Novo Nordisk's Ozempic and Wegovy, are priced significantly higher in the United States compared to other countries, according to a new analysis. The average cost of these medications, which are typically taken over a long period of time, is around $1,000 per month, straining insurers' budgets. The lack of direct negotiations between drugmakers and the U.S. contributes to the vast difference in list prices. The high prices and limited insurance coverage affect accessibility and patient interest. A recent trial by Novo Nordisk showed that Wegovy has additional health benefits beyond weight loss, potentially increasing pressure on insurers to cover these drugs.